Don't want ads? Subscribe or login now.

New Inversion Regs Won't Hinder $16.6B Johnson-Tyco Tie-Up

By Braden Campbell · April 21, 2016, 1:45 PM EDT

The newly unveiled anti-tax inversion regulations that thwarted Pfizer Inc.'s plan to combine with Irish drugmaker Allergan PLC earlier this month will not do the same for Johnson Controls Inc.'s $16.6...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Braden

June 10, 2021
Ex-UAW Leader Gets 28 Months In Feds' Embezzlement Probe
November 04, 2020
3 Takeaways As Gig Cos. Prevail At Polls On Worker Status
November 04, 2020
Calif. Voters Back Uber, Lyft's Worker Classification
August 20, 2020
Lyft, Uber Will Stay Put In California After Court Reprieve
August 10, 2020
Uber And Lyft Can't Treat Calif. Drivers As Contractors
June 03, 2020
Ex-UAW Prez Cops To Role In $1M Embezzlement Scheme
November 15, 2019
3 Takeaways As Uber, NJ Square Off Over $650M Tax Tab
December 05, 2018
KPMG Ruling Casts Skeptical Light On Dukes Decision
November 27, 2018
KPMG Workers Urge Court To Certify Sex Bias Action
September 11, 2018
PwC Blasts Job Applicants' New Cert. Bid In Age Bias Suit

New Inversion Regs Won't Hinder $16.6B Johnson-Tyco Tie-Up

Related Sections

Recent Articles By Braden